Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Guardian Pharmacy Services (GRDN) Accumulated Depreciation & Amortization (2023 - 2025)

Guardian Pharmacy Services' Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $22.3 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 12.96% year-over-year to $22.3 million; the TTM value through Dec 2025 reached $22.3 million, up 12.96%, while the annual FY2025 figure was $22.3 million, 12.96% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $22.3 million at Guardian Pharmacy Services, up from $19.8 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $22.3 million in Q4 2025 and bottomed at $18.2 million in Q4 2023.
  • The 3-year median for Accumulated Depreciation & Amortization is $19.8 million (2024), against an average of $20.1 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization increased 8.43% in 2024 before it grew 12.96% in 2025.
  • A 3-year view of Accumulated Depreciation & Amortization shows it stood at $18.2 million in 2023, then increased by 8.43% to $19.8 million in 2024, then grew by 12.96% to $22.3 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Accumulated Depreciation & Amortization are $22.3 million (Q4 2025), $19.8 million (Q4 2024), and $18.2 million (Q4 2023).